10/21/13  Portland, Ore.

Members of the OHSU Esophageal Cancer Care program published a nomogram to provide guidance on the efficacy of preoperative combined-modality therapy for esophageal cancer. 

This original work titled “Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis", was published in the lead journal of the American Cancer Society, CANCER.

The authors are Drs. Robert Eil, Brian S. Diggs, Samuel J. Wang, James P. Dolan, John G. Hunter, & Charles R. Thomas, Jr..